William Richard White - Jun 20, 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Financial Officer
Signature
/s/ Jonathan Young, Attorney-in-Fact
Stock symbol
AKRO
Transactions as of
Jun 20, 2023
Transactions value $
-$1,020,078
Form type
4
Date filed
6/22/2023, 05:20 PM
Previous filing
Jun 15, 2023
Next filing
Sep 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $123K +17.5K +78.21% $7.01* 39.9K Jun 20, 2023 Direct
transaction AKRO Common Stock Sale -$1.14M -20.8K -52.1% $55.00 19.1K Jun 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -17.5K -7.24% $0.00 224K Jun 20, 2023 Common Stock 17.5K $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are vested and currently exercisable..